Table 3 Prevalences of MDR and non-MDR strains in groups of patients
MDR N (%) | Non MDR (N %) | p-value | |
|---|---|---|---|
Sex | |||
Male | 579 (52) | 535 (48) | 0.187 |
Female | 113 (42) | 158 (58) | 0.006 |
Etiology | |||
Non-traumatic | 104 (47) | 118 (53) | 0.347 |
Traumatic | 588 (51) | 575 (49) | 0.703 |
Bladder management | |||
UC or SC | 559 (55) | 464 (45) | 0.003 |
CIC | 105 (36) | 186 (64) | 0.000 |
SV | 28 (39) | 43 (61) | 0.075 |
Severity of injury | |||
C1–C4, AIS A or B or C | 133 (59) | 94 (41) | 0.010 |
C5–C8, AIS A or B or C | 120 (47) | 134 (53) | 0.380 |
T1–S5, AIS A or B or C | 293 (50) | 290 (50) | 0.901 |
AIS D | 145 (46) | 171 (54) | 0.144 |
Time since injury | |||
< 1 year | 467 (49.0) | 486 (51.0) | 0.538 |
1–5 years | 78 (56.5) | 60 (43.5) | 0.125 |
6–10 years | 37 (50.0) | 37 (50.0) | 1.000 |
> 10 years | 110 (50.0) | 110 (50.0) | 1.000 |
Urinary culture | |||
Gram-negative | 692 (58) | 510 (42) | 0.000 |
Gram-positive | 0 (0) | 183 (100) | 0.000 |